422 related articles for article (PubMed ID: 25879723)
1. Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis.
Pishko GL; Muldoon LL; Pagel MA; Schwartz DL; Neuwelt EA
Fluids Barriers CNS; 2015 Feb; 12():5. PubMed ID: 25879723
[TBL] [Abstract][Full Text] [Related]
2. Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI.
Zhang J; Xue W; Xu K; Yi L; Guo Y; Xie T; Tong H; Zhou B; Wang S; Li Q; Liu H; Chen X; Fang J; Zhang W
Theranostics; 2020; 10(16):7245-7259. PubMed ID: 32641990
[No Abstract] [Full Text] [Related]
3. Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profiling.
Baker LCJ; Boult JKR; Thomas M; Koehler A; Nayak T; Tessier J; Ooi CH; Birzele F; Belousov A; Zajac M; Horn C; LeFave C; Robinson SP
Br J Cancer; 2016 Sep; 115(6):691-702. PubMed ID: 27529514
[TBL] [Abstract][Full Text] [Related]
4. Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain.
Budde MD; Gold E; Jordan EK; Smith-Brown M; Frank JA
NMR Biomed; 2012 May; 25(5):726-36. PubMed ID: 21954124
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive imaging of the functional effects of anti-VEGF therapy on tumor cell extravasation and regional blood volume in an experimental brain metastasis model.
JuanYin J; Tracy K; Zhang L; Munasinghe J; Shapiro E; Koretsky A; Kelly K
Clin Exp Metastasis; 2009; 26(5):403-14. PubMed ID: 19277878
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy.
Hua YC; Gao DZ; Wang KY; Ding XS; Xu WR; Li YB; Shi WW; Sun SB; Li XY
Thorac Cancer; 2023 Nov; 14(31):3133-3139. PubMed ID: 37718465
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues.
Zhuang H; Shi S; Yuan Z; Chang JY
Mol Cancer; 2019 Feb; 18(1):21. PubMed ID: 30732625
[TBL] [Abstract][Full Text] [Related]
8. Imaging angiogenesis of genitourinary tumors.
Zee YK; O'Connor JP; Parker GJ; Jackson A; Clamp AR; Taylor MB; Clarke NW; Jayson GC
Nat Rev Urol; 2010 Feb; 7(2):69-82. PubMed ID: 20084077
[TBL] [Abstract][Full Text] [Related]
9. Effect of Bevacizumab on traumatic penumbra brain edema in rats at different time points.
Ai L; Xin C; Usman M; Zhu Y; Lu H
Tissue Barriers; 2023 Dec; ():2292463. PubMed ID: 38084736
[TBL] [Abstract][Full Text] [Related]
10. Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models.
Quiros-Gonzalez I; Tomaszewski MR; Golinska MA; Brown E; Ansel-Bollepalli L; Hacker L; Couturier DL; Sainz RM; Bohndiek SE
Cancer Res; 2022 Apr; 82(8):1658-1668. PubMed ID: 35404400
[TBL] [Abstract][Full Text] [Related]
11. Novel ultrasound and DCE-MRI analyses after antiangiogenic treatment with a selective VEGF receptor inhibitor.
Watson KD; Hu X; Lai CY; Lindfors HA; Hu-Lowe DD; Tuthill TA; Shalinsky DR; Ferrara KW
Ultrasound Med Biol; 2011 Jun; 37(6):909-21. PubMed ID: 21531499
[TBL] [Abstract][Full Text] [Related]
12. Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance.
Kim AE; Lou KW; Giobbie-Hurder A; Chang K; Gidwani M; Hoebel K; Patel JB; Cleveland MC; Singh P; Bridge CP; Ahmed SR; Bearce BA; Liu W; Fuster-Garcia E; Lee EQ; Lin NU; Overmoyer B; Wen PY; Nayak L; Cohen JV; Dietrich J; Eichler A; Heist R; Krop I; Lawrence D; Ligibel J; Tolaney S; Mayer E; Winer E; Perrino CM; Summers EJ; Mahar M; Oh K; Shih HA; Cahill DP; Rosen BR; Yen YF; Kalpathy-Cramer J; Martinez-Lage M; Sullivan RJ; Brastianos PK; Emblem KE; Gerstner ER
Neuro Oncol; 2024 May; 26(5):965-974. PubMed ID: 38070147
[TBL] [Abstract][Full Text] [Related]
13. VCAM-1-targeted MRI Enables Detection of Brain Micrometastases from Different Primary Tumors.
Cheng VWT; Soto MS; Khrapitchev AA; Perez-Balderas F; Zakaria R; Jenkinson MD; Middleton MR; Sibson NR
Clin Cancer Res; 2019 Jan; 25(2):533-543. PubMed ID: 30389659
[TBL] [Abstract][Full Text] [Related]
14. Emerging findings into molecular mechanism of brain metastasis.
Ni W; Chen W; Lu Y
Cancer Med; 2018 Aug; 7(8):3820-3833. PubMed ID: 29992751
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional effects of metastases in rat brain determined by multimodal MRI.
Serres S; Martin CJ; Sarmiento Soto M; Bristow C; O'Brien ER; Connell JJ; Khrapitchev AA; Sibson NR
Int J Cancer; 2014 Feb; 134(4):885-96. PubMed ID: 23913394
[TBL] [Abstract][Full Text] [Related]
16. Numerical investigation of the pharmacokinetics and pharmacodynamics of the chemotherapeutic drug in avascular and vascular stages of a brain tumor.
Mahmoodi M; Pishevar A; Azargoshasbi F
J Theor Biol; 2023 Nov; 575():111633. PubMed ID: 37839585
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer.
Barr MP; Gray SG; Gately K; Hams E; Fallon PG; Davies AM; Richard DJ; Pidgeon GP; O'Byrne KJ
Mol Cancer; 2015 Feb; 14():45. PubMed ID: 25889301
[TBL] [Abstract][Full Text] [Related]
18. Recombinant mutated human TNF in combination with chemotherapy for stage IIIB/IV non-small cell lung cancer: a randomized, phase III study.
Ma X; Song Y; Zhang K; Shang L; Gao Y; Zhang W; Xue X; Jia H; Geng J; Zhou W; Dang Y; Li E; Ti X; Fan F; Zhang Y; Li M
Sci Rep; 2015 Apr; 4():9918. PubMed ID: 25897826
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view.
Bencsikova B; Bortlicek Z; Halamkova J; Ostrizkova L; Kiss I; Melichar B; Pavlik T; Dusek L; Valik D; Vyzula R; Zdrazilova-Dubska L
BMC Gastroenterol; 2015 Mar; 15():37. PubMed ID: 25888291
[TBL] [Abstract][Full Text] [Related]
20. The effect of individualized nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy: a randomized controlled trial protocol.
van der Werf A; Blauwhoff-Buskermolen S; Langius JA; Berkhof J; Verheul HM; de van der Schueren MA
BMC Cancer; 2015 Mar; 15():98. PubMed ID: 25884881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
